title: New Perspectives in Rheumatology: May You Live in Interesting Times: Challenges and Opportunities in Lupus Research.
authors.affiliation: Emory University School of Medicine, Atlanta, Georgia.
authors.forename: Iñaki
authors.initials: I
authors.lastname: Sanz
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use; D035843:Biomedical Research; D065095:Calcineurin Inhibitors / Q000627:therapeutic use; D064987:Cell- and Tissue-Based Therapy; D002986:Clinical Trials as Topic; D016207:Cytokines / Q000037:antagonists & inhibitors; D056572:Histone Deacetylase Inhibitors / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D058847:Inflammasomes / Q000037:antagonists & inhibitors; D008180:Lupus Erythematosus, Systemic / Q000276:immunology / Q000628:therapy*; D008212:Lymphocyte Depletion; D058990:Molecular Targeted Therapy; D061026:Programmed Cell Death 1 Receptor / Q000037:antagonists & inhibitors; D015363:Quinolones / Q000627:therapeutic use; D012219:Rheumatology
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D065095:Calcineurin Inhibitors; D016207:Cytokines; D056572:Histone Deacetylase Inhibitors; D007166:Immunosuppressive Agents; D058847:Inflammasomes; C105992:PDCD1 protein, human; D061026:Programmed Cell Death 1 Receptor; D015363:Quinolones; C448700:epratuzumab; C511911:belimumab; C476223:laquinimod